FR901228 causes mitotic arrest but does not alter microtubule polymerization

Anti-Cancer Drugs

Volumn 11, Issue 6, 2000, Pages 445-454

  Sandor, Victor ^a,d   Robbins, April R ^b   Robey, Rob ^a   Myers, Tim ^a   Sausville, Edward ^a   Bates, Susan E ^a   Sackett, Dan L ^a,c,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Histone deacetylase inhibitors; Microtubules; Mitosis; Prometaphase

Indexed keywords

CYTOTOXIC AGENT; FR 901228; TUBULIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE PHASE; CELL STRAIN MCF 7; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BRIDGED COMPOUNDS; CELL CYCLE; DEPSIPEPTIDES; FLOW CYTOMETRY; G2 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; MICROTUBULES; MITOSIS; MOLECULAR STRUCTURE; PEPTIDES, CYCLIC; TAXOIDS; TIME FACTORS; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0033850625     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200007000-00005     Document Type: Article

References (24)

1. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromo bacterium violaceum No 968 I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity
2. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromo bacterium violaceum No 968 III. Antitumor activities on experimental tumors in mice
3. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968, on H-ras transformed NTH3T3 cells
4. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
5. Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells
6. Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells
7. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen
8. Molecular targets in the National Cancer Institute drug screen
9. Expression of transforming grown factors alpha (TGF alpha) in breast cancer
10. Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data
11. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs
12. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases
13. Isolation of microtubule protein from mammalian brain frozen for extended periods of time
14. Charge-shielding and the paradoxical stimulation of tubulin polymerization by guanidine hydrochloride
15. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents
16. Flow cytometry of mitotic cells
17. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
18. Effects of cell density and trichostatin A on the expression of HDAC1 and p57(Ktp2) in Hep 3B cells
19. Mitosis and checkpoints that control progression through mitosis in vertebrate somatic cells
20. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle
21. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
22. Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53
23. Understanding and controlling the cell cycle with natural products
24. Local unfolding and the stepwise loss of the functional properties of tubulin